ArticleCureus2025
Amoxicillin-Induced Hypersensitivity Versus Viral Exanthem in Epstein-Barr Virus Infection: A Paediatric Case Series.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Patch Testing in Paediatric Drug Hypersensitivity Reactions: Current Evidence and Clinical Implications.Contact dermatitis · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Epstein-Barr virus (EBV) infection is often associated with skin rashes following aminopenicillin treatment, such as amoxicillin, typically considered a benign and transient reaction. However, distinguishing between non-allergic exanthems and true hypersensitivity remains a clinical challenge, especially in children and adolescents. This case series reports three cases of adolescents who developed generalized exanthematous eruptions following the administration of amoxicillin during acute EBV infection, confirmed by serological testing. All patients underwent standardized allergy evaluation through drug provocation testing at least ten weeks after rash resolution, which confirmed true delayed hypersensitivity to amoxicillin. These three pediatric cases reinforce the need for heightened clinical vigilance when a skin rash occurs during EBV infection treated with amoxicillin. While such rashes are often attributed to transient viral-drug interactions, our findings highlight the importance of considering the possibility of true amoxicillin hypersensitivity. Careful evaluation, including comprehensive allergy work-up when appropriate, is essential to accurately identify a true aminopenicillin allergy and thereby reduce the risk of future severe hypersensitivity reactions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.